Dan Leonard Stock Analyst Profile - UBS Research Coverage - Stocknear

Dan Leonard

Stock Analyst at UBS

(4.76)
# 799
Out of 5,493 analysts
298
Total ratings
Success rate
Average return

36 Stocks

Name Action PT Current % Upside Ratings Updated
GH Guardant Health
Maintains: Strong Buy
70 80
60.03 33.27% 10 Sep 25, 2025
TXG 10x Genomics
Maintains: Neutral
12 13
11.72 10.92% 6 Aug 8, 2025
EXAS Exact Sciences
Maintains: Neutral
61 53
53.57 -1.06% 10 Aug 7, 2025
CERT Certara
Maintains: Buy
18 15
11.8 27.12% 10 Aug 7, 2025
MEDP Medpace Hldgs
Downgrades: Sell
300 305
496.79 -38.61% 2 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
460 500
464.24 7.7% 17 Jul 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
240 225
184.84 21.73% 15 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
185 225
179.5 25.35% 16 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1530 1350
1204.26 12.1% 9 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 70
51.85 35% 11 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
57 45
31.04 44.97% 11 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
355 310
271.15 14.33% 20 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
145 115
84.05 36.82% 2 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
122 99
92.78 6.7% 1 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 25
11.85 110.97% 7 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
250 185
148.58 24.51% 6 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 9
9.2 -2.17% 2 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
22.59 54.94% 4 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 150
123.41 21.55% 20 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
225 200
91.69 118.13% 16 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
14 11
2.82 290.07% 6 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
70
162.97 -57.05% 7 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
7
13.22 -47.05% 2 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
160
n/a n/a 12 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
345
291.75 18.25% 12 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
260
163.79 58.74% 5 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Underperform
1
n/a n/a 3 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
160 145
188.98 -23.27% 10 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
95 90
67.21 33.91% 12 Feb 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 64
43.9 44.99% 2 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
330 340
280.67 21.14% 11 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
24
25.72 -6.69% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
4 2
n/a n/a 3 May 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
45 35
7.7 354.55% 11 Aug 14, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
80 55
n/a n/a 3 May 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Hold
18 0
n/a n/a 3 May 7, 2018